In 2007, a biopsy revealed Donna Gaidamak had Stage 4 lung cancer that had metastasized to her brain. Donna was tested for the ALK gene rearrangement with the Vysis ALK Break Apart FISH Probe Test Kit from Abbott. Results proved she was ALK positive and she was immediately put on XALKORI® (crizotinib). Today, Donna is back to doing the activities she loves: biking, skiing, kayaking and sailing.
Intended Use
The Vysis ALK Break Apart FISH Probe Kit is intended to detect rearrangements involving the ALK gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens.
Learn how Abbott delivered improved sensitivity , consolidation, and cost savings with the m2000 RealTime System.
Learn how Abbott helped this lab achieve a faster response time for physicians and patients by consolidating tests onto one system .
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
